Jason Tagler is a Managing Partner of Camden Partners and joined the firm in 2005. He leads growth-equity-stage investments in software and tech services companies. Mr. Tagler has invested in over 25 businesses and represents Camden on the boards of its portfolio companies.
Founded in 1995, Camden Partners is a growth equity firm that helps the management teams of enterprise software and technology-enabled services companies scale their businesses. Camden has invested in 85 companies across six growth-equity funds and is known for providing creative and flexible growth capital. By focusing on the same strategy for over 25 years, the firm’s partners leverage deep domain expertise and a network of operating executives to help management teams grow revenue and cash flow. With initial equity checks between $5 million and $15 million, Camden is a preferred partner for owner-operators who are dilution sensitive.
Mr. Tagler leads Camden investments with the following profile:
To submit a potential investment for consideration:
Navigate to the Contact Jason page and paste an investment summary in the message box. If it is a good fit for Mr. Tagler’s investment goals/style and the criteria above, you will receive a response with next steps within 5 business days.
If you need to create an investment summary or want to improve what you have, please visit PitchCreator.com. You will find online courses and other resources on how to create an elevator pitch, investment summary, and slide deck.
Real estate software which simplifies lending technology and marketing automation for mortgage loan officers at banks and other top mortgage lenders.
Enterprise software and big-data analytics platform for the CMO suite.
Led $13.5 million Series D growth round with $10 million commitment from Camden.
Talent analytics in the cloud and leader in pre-hiring assessments.
Led $8 million investment and recap.
Cyber-security in the cloud and leader in DDoS mitigation.
Led series B round; sold to Akamai for $400+ million in 2014
Supply chain planning software in the cloud and leader in S&OP/demand prediction.
Led $22.5 million series C round; sold to E2Open in 2017
LBO of private-label manufacturer of oral care products.
Sold for $750 million to Perrigo in 2019
SaaS platform for property management.
Led multiple growth equity investments; exited after the IPO.
CDMO with specialization in gene therapy
Invested in the multiple growth equity rounds; sold to Catalent for $1.2 billion.